A novel tetracycline-inducible viral replication switch

Human Gene Therapy

Volumn 10, Issue 3, 1999, Pages 419-427

  Yao, Feng ^a   Eriksson, Elof ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; TETRACYCLINE; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; DNA TRANSFECTION; HERPES SIMPLEX VIRUS 1; VIRUS PLAQUE; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOMEGALOVIRUS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; GENES, REGULATOR; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; OSTEOSARCOMA; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; TETRACYCLINE; TRANSFECTION; VERO CELLS; VIRAL PROTEINS; VIRAL VACCINES; VIRUS REPLICATION;

DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1; MAMMALIA; RNA VIRUSES;

EID: 0033540619     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018869     Document Type: Article

References (26)

1. ANDERSON, W.F. (1998). Human gene therapy. Nature (London) 392 (Suppl.), 25-30.
2. BARADARAN, K., DABROWSKI, C.E., and SCHAFFER, P.A. (1994). Transcriptional analysis of the region of the herpes simplex virus type 1 genome containing the UL8, UL9, and UL10 genes and identification of a novel delayed-early gene product, OBPC. J. Virol. 68, 4251-4261.
3. BERKNER, K.L. (1992). Expression of heterologous sequences in adenoviral vectors. Curr. Top. Microbiol. Immunol. 158, 39-66.
4. BOSHART, M., WEBER, F., JAHN, G., DORSCH-HASLER, K., FLECKENSTEIN, B., and SCHAFFNER, W. (1985). A very strong enhancer is located upstream of an immediate-early gene of human cytomegalovirus. Cell 41, 521-530.
5. BRUCKNER, R.C., CRUTE, J.J., DODSON, M.S., and LEHMAN, I.R. (1991). The herpes simplex virus I origin binding protein: A DNA helicase. J. Biol. Chem. 266, 2669-2674.
6. CHALLBERG, M.D., and KELLY, T.J. (1989). Animal virus DNA replication. Annu. Rev. Biochem. 58, 671-717.
7. DEB, S., and DEB, S. (1991). A 269-amino-acid segment with a pseudo-leucine zipper and a helix-turn-helix motif codes for the sequence-specific DNA-binding domain of herpes simplex virus type 1 origin-binding protein. J. Virol. 65, 2829-2838.
8. FIERER, D.A., and CHALLBERG, M.D. (1992). Purification and characterization of UL9, the herpes simplex virus type 1 origin binding protein. J. Virol. 66, 3986-3995.
9. FOECKING, M.K., and HOFSTETTER, H. (1986). Powerful and versatile enhancer-promoter unit for mammalian expression vectors. Gene 45, 101-105.
10. GRAHAM, F.L., and PREVEC, L. (1992). Adenovirus-based expression vectors and recombinant vaccines. BioTechnology 20, 363-390.
11. HAZUDA, D.J., PERRY, H.C., and McCLEMENTS, W.L. (1992). Cooperative interactions between replication origin-bound molecules of herpes simplex virus origin-binding protein are mediated via the amino terminus of the protein. J. Biol. Chem. 267, 14309-14315.
12. MALIK, A.K., and WELLER, S.K. (1996). Use of transdominant mutants of the origin-binding protein (UL9) of herpes simplex virus type 1 to define functional domains. J. Virol. 70, 7859-7866.
13. MARCONI, P., KRISKY, D., OLIGINO, T., POLIANI, P.L., RAMAKRISHNAN, R., GOINS, W.F., FINK, D.J., and GLORIOSO, J.C. (1996). Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc. Natl. Acad. Sci. U.S.A. 93, 11319-11320.
14. McGEOCH, D.J., DALRYMPLE, M.A., DOLAN, A., McNAB, D., PERRY, L.J., TAYLOR, P., and CHALLBERG, M.D. (1988). Structures of herpes simplex virus type 1 genes required for replication of virus DNA. J. Virol. 62, 444-453.
15. MULLIGAN, R.C. (1993). The basic science of gene therapy. Science 260, 926-932.
16. OLIVO, P.D., NELSON, N.J., and CHALLBERG, M.D. (1988). Herpes simplex virus DNA replication: The UL9 gene encodes an origin-binding protein. Proc. Natl. Acad. Sci. U.S.A. 85, 5414-5418.
17. PERRY, H.C., HAZUDA, D.J., and McCLEMENTS, W.L. (1993). The DNA binding domain of herpes simplex virus type 1 origin binding protein is a transdominant inhibitor of virus replication. Virology 193, 73-79.
18. SCHMIDT, E.V., CHRISTOPH, G., ZELLER, R., and LEDER, P. (1990). The cytomegalovirus enhancer: A pan-active control element in transgenic mice. Mol. Cell. Biol. 10, 4406-4411.
19. STOW, N.D. (1992). Herpes simplex virus origin-dependent replication in insect cells using recombinant baculoviruses. J. Gen. Virol. 73, 313-321.
20. STOW, N.D., HAMMARSTEN, O., ARBUCKLE, M., and ELIAS, P. (1993). Inhibition of herpes simplex virus type 1 DNA replication by mutant forms of the origin-binding protein. Virology 196, 413-418.
21. WEIR, H.M., CALDER, J.M., and STOW, N.D. (1989). Binding of the herpes simplex virus type 1 UL9 gene product to an origin of viral DNA replication. Nucleic Acids Res. 17, 1409-1425.
22. WELLER, S.K. (1991). Genetic analysis of HSV genes required for genome replication. In Herpesvirus Transcription and Its Regulation. E. Wagner, ed. (CRC Press) pp. 105-135.
23. WU, C.A., NELSON, N.J., McGEOCH, D.J., and CHALLBERG, M.D. (1988). Identification of herpes simplex virus type 1 genes required for origin-dependent DNA synthesis. J. Virol. 62, 435-443.
24. YAO, F., and COURTNEY, R.J. (1989). A major transcription regulatory protein (ICP4) of herpes simplex virus type 1 is associated with purified virions. J. Virol. 63, 3338-3344.
25. YAO, F., and SCHAFFER, P.A. (1995). Cellular factor(s) specified by the osteosarcoma line, U20S, can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1. J. Virol. 69, 6249-6258.
26. YAO, F., SEVENSJO, T., WINKER, T., LU, M., ERIKSSON, C., and ERIKSSON, E. (1998). Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulated inducible gene expression in mammalian cells. Hum. Gene Ther. 9, 1939-1950.